Businesses that design, manufacture, sell, and service durable medical devices, single-use medical consumables, implantable devices, and life-science research instruments, plus the associated reagents, software, and service contracts. Four structural features dominate the disclosure pattern and therefore the KPI set: (1) a capital + consumable + service razor-blade economic model where each new pl
| Ticker | Company | Their metric | Period | YoY | A year ago |
|---|---|---|---|---|---|
| PACB | Pacific Biosciences of California, Inc. | Revio Sequencing Systems Included in Instrument Revenue | FY2026-Q1 | +25.0% | -57.1% |
| IRIX | IRIDEX Corporation | Cyclo-G6 Probes Sold | FY2026-Q2 | +35.1% | -13.2% |
| TNDM | Tandem Diabetes Care, Inc. | International Insulin Pump Shipments | FY2026-Q2 | +22.2% | -10.0% |
| MASS | 908 Devices Inc. | Cumulative handheld and desktop installed base | FY2026-Q2 | +22.9% | +8.8% |
| BNGO | Bionano Genomics, Inc. | Nanochannel Array Flow Cells Sold | FY2026-Q2 | +27.5% | +17.3% |
| CVRX | CVRx, Inc. | United States Heart Failure Revenue Units | FY2026-Q2 | +20.4% | +14.2% |
| BLFS | BioLife Solutions, Inc. | Unique commercial cell and gene therapies using biopreservation media | FY2026-Q2 | +12.5% | +6.7% |
| ELMD | Electromed, Inc. | Direct sales representatives | FY2025-Q3 | +7.8% | +6.3% |
| GEHC | GE HealthCare Technologies Inc. | Book-to-bill ratio | FY2026-Q2 | +0.1% | +0.0% |
| ALGN | Align Technology, Inc. | Doctor customers | FY2026-Q2 | +5.4% | +8.7% |
| EYE | National Vision Holdings, Inc. | Comparable store traffic | FY2025-Q2 | -2.3 pts | +1.6 pts |
| SIBN | SI-BONE, Inc. | United States Physicians Performing Procedures | FY2026-Q2 | +19.1% | +25.2% |
| BLCO | Bausch + Lomb Corporation | Bausch + Lomb ULTRA Revenue | FY2026-Q1 | +5.6% | +12.5% |
| BBNX | Beta Bionics, Inc. | New Patient Starts from Multiple Daily Injections | FY2026-Q1 | -1.0 pts | +7.0 pts |
| PRCT | PROCEPT BioRobotics Corporation | United States AquaBeam robotic systems installed base | FY2026-Q1 | +39.9% | +54.5% |
| RXST | RxSight, Inc. | Light Adjustable Lens Units Sold | FY2026-Q2 | -9.0% | +13.1% |
| SRTS | Sensus Healthcare, Inc. | Superficial Radiotherapy Systems Sold | FY2026-Q2 | -42.1% | -17.4% |
| RMD | ResMed Inc. | Lives changed | FY2025-Q3 | -13.2% | +11.5% |
| XRAY | DENTSPLY SIRONA Inc. | Capital expenditures | FY2025-Q4 | -19.6% | +27.5% |
| MYO | Myomo, Inc. | MyoPro revenue units | FY2026-Q2 | -35.4% | +12.7% |
| SNWV | SANUWAVE Health, Inc. | UltraMist Systems Sold | FY2026-Q2 | -29.3% | +61.1% |
A side-by-side appears only when three or more companies report the same metric in the same unit under their own definition. Companies are listed in value order, not ranked: whether a higher number is better is not asserted.